








Don E. Bobo Jr. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Don E. Bobo Jr.
Former Corporate Vice President, Strategy and Corporate Development at Edwards Lifesciences Corporation


View Full Profile
Are you Don E. Bobo Jr.? Claim your profile


 


Sign up for Equilar Atlas and view Don E. Bobo Jr.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Don E. Bobo Jr.'s  network and community.
												FOLLOW changes in Don E. Bobo Jr.'s employment and money-in-motion.
												CONNECT with Don E. Bobo Jr. through your network of contacts.
												








Don E. Bobo Jr.'s Executive Work History


Past
To view Don E. Bobo Jr.'s complete executive work history, sign up now
Age
55

 
 


Don E. Bobo Jr.'s Biography



Donald E. Bobo, Jr., age 55. Mr. Bobo has been Corporate Vice President since 2007 and is currently responsible for Edwards' corporate strategy and corporate development functions. In addition, Mr. Bobo has executive responsibility for the transcatheter mitral and tricuspid therapies organization and heart failure initiatives, as well as the healthcare solutions and commercial services team. Mr. Bobo has more than 30 years of experience in the medical products and healthcare industry including various operating roles at Edwards such as vice president and general manager of the global heart valve therapy business and global valve manufacturing ...
(Read More)

			Donald E. Bobo, Jr., age 55. Mr. Bobo has been Corporate Vice President since 2007 and is currently responsible for Edwards' corporate strategy and corporate development functions. In addition, Mr. Bobo has executive responsibility for the transcatheter mitral and tricuspid therapies organization and heart failure initiatives, as well as the healthcare solutions and commercial services team. Mr. Bobo has more than 30 years of experience in the medical products and healthcare industry including various operating roles at Edwards such as vice president and general manager of the global heart valve therapy business and global valve manufacturing operations. Prior to joining Edwards in 1995, Mr. Bobo held a variety of roles with increasing levels of responsibility with American Hospital Supply and Baxter Healthcare Corporation, including research and development, business development, operations and general management. Currently, Mr. Bobo serves on the board of Innerspace Neuro Solutions Inc. and as Vice Chair of the board of the California Life Sciences Association. He received a bachelor's degree in mathematics from Bob Jones University, and a master's degree in engineering from the University of Southern California.
		
Source: Edwards Lifesciences Corporation on 03/30/2017
		
	

 






Sign up for Equilar Atlas and view Don E. Bobo Jr.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Don E. Bobo Jr.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Don E. Bobo Jr.'s  network and community.
												FOLLOW changes in Don E. Bobo Jr.'s employment and money-in-motion.
												CONNECT with Don E. Bobo Jr. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Don E. Bobo Jr.


















Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Daniel A. DeMatteo
Executive Chairman, GameStop Corp.









David J. O'Connor
President and CEO, The Madison Square Garden Company












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993


















Donald E. Bobo, Jr. CLSA Board of Directors

















































































































Become a MemberLog In

About
Industry Intelligence
Institute
Media Center
Contact


 

















Board Of Directors







 
Donald E. Bobo, Jr. ChairCorporate Vice President, Strategy & Corporate Development, Edwards Lifesciences IncDonald E. Bobo, Jr., has been corporate vice president since 2007 and is currently responsible for the company’s corporate strategy and corporate development functions. In addition, Bobo has executive responsibility for transcatheter mitral and tricuspid therapies as well as the healthcare solutions and commercial services team. Bobo has more than 30 years of experience in the medical products and healthcare industry in various operating roles at Edwards, including vice president and general manager of the global heart valve therapy business and global valve manufacturing operations. Prior to joining Edwards, Bobo held a variety of roles with increasing levels of responsibilities with American Hospital Supply and Baxter Healthcare. Currently, Bobo serves on the board of InnerSpace Neuro Inc. and represents Edwards on the board of a number of medical device startup companies developing novel therapies for the treatment of structural heart disease.  In addition, Bobo is chairman, board member and member of the executive committee of the California Life Sciences Association (CLSA).









Login


Email



Password


 Remember Me





Lost your password?





Reset Password


Username or E-mail:







Log in


















				MENU							



Advocacy

Take Action
Federal Advocacy
State Advocacy
Local Advocacy
Protect Access and Innovation
Policy & Advocacy News
CLSAPAC
CLSA Capitol Connection
Become an Advocate


Member Resources

Join/Renew Today
Business Resources

Career Center
Lab Space
Tax Incentives
Local Resources

Sacramento
Bay Area
Los Angeles
San Diego
DC




CLSA Wire

Press Releases
In the News
Local Issues
Washington
Sacramento
Blog
Op-Eds


Industry Intelligence

2017 California Life Sciences Industry Report
Media Center
Policy Papers


Power Purchasing
Membership Dues
Member Directory
Why California?


Bulletin
Events

Calendar of Events
Submit an Event
Pantheon
Program Sponsorship
Previous Events


Innovation

Services and Offerings
CLSA Fellows

BiosciDB Research Database


Partnering Days
CLSI
CLSI Carb-X


About

CLSA Team
CLSA Board of Directors
CLSA Career Opportunities


Institute

Innovation
STEM Education
Workforce Surveys
Life Science Careers
Team
Board of Directors


Contact


 






   Donald Bobo | Edwards Lifesciences Corporation | ZoomInfo.com

 






Donald E.  Bobo, Jr., Corporate Vice President General Manager Heart Valve Therapy, Edwards Lifesciences


























&timesJavascript is disabled
























Market Profiles



Login
Sign up



Login


Sign up








 







 Edit

Person













Donald E.  Bobo, Jr.



Corporate Vice President General Manager Heart Valve Therapy
at
Edwards Lifesciences


Location: 





Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop









Donald E.  Bobo, Jr.



Corporate Vice President General Manager Heart Valve Therapy
at
Edwards Lifesciences


Location: 




Add to My Lists

Claim

Share


Copy the following code on your page/blog


Suggested widget size



Mobile



Desktop




Donald E. Bobo, Jr., has been corporate vice president, heart valve therapy since 2007 and is responsible for the company’s global surgical heart valve business, including valve replacement and repair devices. Bobo is also currently responsible for the company’s Information Technology (IT) group. Bobo has more than 30 years of experience in the medical products and healthcare industry where he most recently served as Edwards’ vice president and general manager of transcatheter mitral repair and as vice president, corporate strategy. Bobo has held a variety of roles with increasing levels of responsibilities with American Hospital Supply and Baxter Healthcare, including business development, R&D, operations and general management. Prior to joining Edwards in 1995, he served as director and general manager of the non-invasive monitoring business unit of InnerSpace Medical, a medical device startup company where he remains an outside director. He currently represents Edwards on the board of CardioKinetix. He received a bachelor’s degree in mathematics from Bob Jones University, and a master’s degree in engineering from the University of Southern California.



1

Companies in Career





N/A

Related Markets





4

Colleagues





N/A

Related Investments








Alias
N/A



Industry
Medical Device, Equipment, Supplies Manufacturing




Tags
Mathematics




Topics of Influence












N/A







N/A



























Careers








Achievements








Investments








Related People






 Edit
View all 



Donald E.  Bobo, Jr.Career











Edwards Lifesciences



Corporate Vice President General Manager Heart Valve Therapy








Competencies










 Edit
View all 



Donald E.  Bobo, Jr.Education (2)










University of Southern California.


Engineering










Bob Jones University


Mathematics









 Edit



Donald E.  Bobo, Jr.Achievements and Recognitions





Add Milestone


No milestones has been recorded for Donald E.  Bobo, Jr.






 Edit



Donald E.  Bobo, Jr.Links





Add Link


No links has been recorded for Donald E.  Bobo, Jr.









Donald E.  Bobo, Jr.Investments/Acquisitions





No investments has been recorded for Donald E.  Bobo, Jr.









Donald E.  Bobo, Jr.Investments Representing Others





No investment reps has been recorded for Donald E.  Bobo, Jr.








Donald E.  Bobo, Jr.Related People








Colleagues at Edwards Lifesciences







Dirk Rassloff

Group Manager Strategic Marketing and Market Development, Global Critical Care
2015









Dirksen Lehman

Corporate Vice President, Public Affairs
Jun-2013









Aimee Weisner

Corporate Vice President,  General Counsel
Jan-2011









Dirksen Lehman

Vice President, Govt Affairs & Reimbursement
Nov-2007












View all 



Donald E.  Bobo, Jr.Recommended Market Profiles (8)








Telemedicine

10,000 or More employees
19 companies








Social Media Marketing (ChiefMartec.com)

5,000 - 10,000 employees
111 companies








Big Data Universe List of Lists

10,000 or More employees
533 companies








Aggregated Marketing Technology

10,000 or More employees
2650 companies








Shared Economy Landscape (Jeremiah Owyang)

10,000 or More employees
267 companies








Inside Sales Landscape

10,000 or More employees
650 companies




















































BidaskClub Lowers CA Inc. (NASDAQ:CA) to Sell - American Banking News




















































Home
Get Email Updates
About
Disclaimer
Contact
Privacy Policy









 
			

















Business News
U.S. News
World News
Stock Ratings

Analysts' Upgrades
Analysts' Downgrades
Analysts' EPS Estimates
Analysts' Price Targets
Analysts' New Coverage


Corporate Earnings

Earnings Results
Earnings Guidance
Earnings Previews


Dividends
Insider Trades
Options
Press Releases






















CA Inc. - Get News & Ratings Daily

		Enter your email address below to get the latest news and analysts' ratings for CA Inc. with our FREE daily email newsletter:



 











 Recent Stories


eBay Inc. (NASDAQ:EBAY) Price Target Raised to $40.00 at Benchmark Co.


SM Energy Company (NYSE:SM) Earns Neutral Rating from Analysts at Bank of America Corporation


Goldman Sachs Group, Inc. (The) Analysts Give Facebook, Inc. (NASDAQ:FB) a $180.00 Price Target


Bank of America Corporation Initiates Coverage on PDC Energy, Inc. (NASDAQ:PDCE)


SunTrust Banks, Inc. Reiterates Buy Rating for TD Ameritrade Holding Corporation (NASDAQ:AMTD)


McDonald’s Corporation (MCD) PT Set at $172.00 by Nomura


Citigroup Inc. Lowers Drax Group PLC (DRXGY) to Neutral


Deutsche Lufthansa AG (LHA) Given a €18.50 Price Target at J P Morgan Chase & Co


Goldman Sachs Group, Inc. (The) Reiterates €13.62 Price Target for Deutsche Lufthansa AG (ETR:LHA)


Dominion Diamond Corporation (DDC) Rating Lowered to Neutral at Citigroup Inc.


Canadian Natural Resources Limited (NYSE:CNQ) Rating Increased to Overweight at Morgan Stanley


Parsley Energy, Inc. (NYSE:PE) Now Covered by Analysts at Bank of America Corporation


Masimo Corporation (MASI) Price Target Increased to $105.00 by Analysts at Roth Capital


BioTelemetry, Inc. (BEAT) Price Target Increased to $44.00 by Analysts at Benchmark Co.


Whiting Petroleum Corporation (WLL) Earns Underperform Rating from Analysts at Bank of America Corporation


J P Morgan Chase & Co Analysts Give Apple Inc. (AAPL) a $165.00 Price Target


Goldman Sachs Group, Inc. (The) Analysts Give Software AG (SOW) a €36.00 Price Target


BHP Billiton Limited (NYSE:BHP) Downgraded by Citigroup Inc. to Neutral


Boeing Company (The) (BA) Stock Rating Upgraded by Bank of America Corporation


Puma Biotechnology Inc (NYSE:PBYI) Rating Reiterated by Leerink Swann





 






						BidaskClub Lowers CA Inc. (NASDAQ:CA) to Sell					

July 1st, 2017  • 0 comments • Filed Under •
 by ABMN Staff



							Filed Under: Analysts Downgrades • Market News 






Tweet










CA Inc. (NASDAQ:CA) was downgraded by investment analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday.
A number of other equities analysts have also recently weighed in on the stock. Citigroup Inc.  restated a “neutral” rating and set a $34.00 price objective (up from $33.00) on shares of CA in a research report on Sunday, May 14th. Zacks Investment Research cut shares of CA from a “hold” rating to a “sell” rating in a research report on Tuesday, May 16th. DA Davidson  reiterated a “neutral” rating and issued a $12.00 target price on shares of CA in a research report on Friday, May 19th. Raymond James Financial, Inc.  reiterated a “market perform” rating on shares of CA in a research report on Thursday, June 22nd. Finally, Sanford C. Bernstein  reiterated an “underperform” rating and issued a $28.00 target price on shares of CA in a research report on Wednesday. Five analysts have rated the stock with a sell rating, eight have issued  a hold rating and five have assigned  a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $34.88.


 Get CA Inc. alerts:



CA (NASDAQ:CA) traded up 0.58% during midday trading on Friday, hitting $34.47. 3,427,888 shares of the stock were exchanged. The firm’s 50 day moving average price is $32.41 and its 200 day moving average price is $32.25. CA has a 12 month low of $30.01 and a 12 month high of $36.54. The company has a market cap of $14.40 billion, a PE ratio of 18.63 and a beta of 0.92. 




CA (NASDAQ:CA) last released its earnings results on Thursday, May 11th. The technology company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.05. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $996.59 million. CA had a net margin of 19.20% and a return on equity of 17.15%. CA’s revenue was up .3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.60 EPS.  On average, equities research analysts forecast that  CA will post $2.38 earnings per share for the current fiscal year. 
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 13th. Shareholders of record on Thursday, May 25th were paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 2.96%. The ex-dividend date  was Tuesday, May 23rd. CA’s dividend payout ratio (DPR) is presently 55.14%. 
COPYRIGHT VIOLATION NOTICE: This report was originally  reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was illegally copied and republished in violation of U.S. & international copyright law. The original version of this report can be read at https://www.americanbankingnews.com/2017/07/01/bidaskclub-lowers-ca-inc-nasdaqca-to-sell.html. 
In other CA news, insider Ayman Sayed sold 30,194 shares of the stock in a transaction dated Wednesday, June 21st. The shares were sold at an average price of $35.62, for a total transaction of $1,075,510.28. Following the completion of the transaction, the insider now owns 168,455 shares of the company’s stock, valued at $6,000,367.10. The sale was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own  0.90% of the company’s stock. 
Hedge funds and other institutional investors have recently made changes to their positions in the company. Fort Pitt Capital Group LLC boosted its stake in shares of  CA by 0.6% in the first quarter. Fort Pitt Capital Group LLC now owns 982,181 shares of the technology company’s stock valued at $31,155,000 after buying an additional 6,328 shares in the last quarter.  TLP Group LLC acquired a new stake in shares of  CA during the first quarter valued at about $381,000.  Cambridge Investment Research Advisors Inc. boosted its stake in shares of  CA by 24.3% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 78,590 shares of the technology company’s stock valued at $2,493,000 after buying an additional 15,365 shares in the last quarter.  Victory Capital Management Inc. boosted its stake in shares of  CA by 36.4% in the first quarter. Victory Capital Management Inc. now owns 222,795 shares of the technology company’s stock valued at $7,067,000 after buying an additional 59,398 shares in the last quarter.  Finally, Pacer Advisors Inc. boosted its stake in shares of  CA by 30.8% in the first quarter. Pacer Advisors Inc. now owns 14,114 shares of the technology company’s stock valued at $448,000 after buying an additional 3,324 shares in the last quarter. 71.69% of the stock is owned by institutional investors. 
CA Company Profile
CA, Inc (CA) is engaged in providing software solutions enabling customers to plan, develop, manage and secure applications and enterprise environments across distributed, cloud, mobile and mainframe platforms. The Company operates through three business segments: Mainframe Solutions, Enterprise Solutions and Services.





Receive News & Ratings for CA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



 































Leave a Reply

Click here to cancel reply.



Name (required)

Mail (will not be published) (required)

Website






Wordpress Hashcash needs javascript to work, but your browser has javascript disabled. Your comment will be placed in moderation!











			© Copyright American Banking and Market News 2006-2017. All rights reserved. 

Privacy Policy and Disclosures |
			About | Advertising 
			| Contact







Content on this website is not meant to be a recommendation or an offer to buy or sell any security. Click here to read our full disclaimer.


















































Don E. Bobo Jr. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Don E. Bobo Jr.
Former Corporate Vice President, Strategy and Corporate Development at Edwards Lifesciences Corporation


View Full Profile
Are you Don E. Bobo Jr.? Claim your profile


 


Sign up for Equilar Atlas and view Don E. Bobo Jr.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Don E. Bobo Jr.'s  network and community.
												FOLLOW changes in Don E. Bobo Jr.'s employment and money-in-motion.
												CONNECT with Don E. Bobo Jr. through your network of contacts.
												








Don E. Bobo Jr.'s Executive Work History


Past
To view Don E. Bobo Jr.'s complete executive work history, sign up now
Age
55

 
 


Don E. Bobo Jr.'s Biography



Donald E. Bobo, Jr., age 55. Mr. Bobo has been Corporate Vice President since 2007 and is currently responsible for Edwards' corporate strategy and corporate development functions. In addition, Mr. Bobo has executive responsibility for the transcatheter mitral and tricuspid therapies organization and heart failure initiatives, as well as the healthcare solutions and commercial services team. Mr. Bobo has more than 30 years of experience in the medical products and healthcare industry including various operating roles at Edwards such as vice president and general manager of the global heart valve therapy business and global valve manufacturing ...
(Read More)

			Donald E. Bobo, Jr., age 55. Mr. Bobo has been Corporate Vice President since 2007 and is currently responsible for Edwards' corporate strategy and corporate development functions. In addition, Mr. Bobo has executive responsibility for the transcatheter mitral and tricuspid therapies organization and heart failure initiatives, as well as the healthcare solutions and commercial services team. Mr. Bobo has more than 30 years of experience in the medical products and healthcare industry including various operating roles at Edwards such as vice president and general manager of the global heart valve therapy business and global valve manufacturing operations. Prior to joining Edwards in 1995, Mr. Bobo held a variety of roles with increasing levels of responsibility with American Hospital Supply and Baxter Healthcare Corporation, including research and development, business development, operations and general management. Currently, Mr. Bobo serves on the board of Innerspace Neuro Solutions Inc. and as Vice Chair of the board of the California Life Sciences Association. He received a bachelor's degree in mathematics from Bob Jones University, and a master's degree in engineering from the University of Southern California.
		
Source: Edwards Lifesciences Corporation on 03/30/2017
		
	

 






Sign up for Equilar Atlas and view Don E. Bobo Jr.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Don E. Bobo Jr.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Don E. Bobo Jr.'s  network and community.
												FOLLOW changes in Don E. Bobo Jr.'s employment and money-in-motion.
												CONNECT with Don E. Bobo Jr. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Don E. Bobo Jr.


















Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Daniel A. DeMatteo
Executive Chairman, GameStop Corp.









David J. O'Connor
President and CEO, The Madison Square Garden Company












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993























Bobo Donald E Jr - Insider Stock Trading - OpenInsider











Sector

All Sectors

Group by Sector


Aerospace
Agriculture
Automobile
Building
Business Services
Chemical
Electrical
Energy
Fashion
Financial
Food & Beverage
Fund
Healthcare
Household
Insurance
Machinery
Media
Metals
Mining
Other
Personal Services
Real Estate
Retail
Technology
Telecom
Transportation
Utility




Industry

All Industries

Group by Industry






Insiders
Filings


All
Purchases
Sales

CIK: 1196661 - Address: One Edwards Way, Irvine, CA 92614 64 results 

						Links
						


SECYahooGoogleFinvizTradingViewStockChartsStockTwitsDownload CSV 













TC
Stat
Stk
Ins
Fil
+d
+w
+m
+q
+h
+y
avg


S%ret1132-1-04712217S%wins63522732354843 




Filing Date
T Date
Ticker
IssuerInc Sector
IndIndustry
Owner
oSt
Rel
Title
T
TVal
Price
L
Qty
oc
Own
H
r2y
r1y
r6m
r3m
r6w
r3w
r7d
r3d
f1d
f1w
f1m
f3m
f6m
f1y



7/3/17 16:056/29/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d25044.62066107D
7/3/17 16:056/29/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-656117.150-6-5107D
5/12/17 19:125/10/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d00.00331112104D6952121171300
5/9/17 19:075/5/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.dm85244.6233192499D77423221516001
5/9/17 19:075/5/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.dm-2,108110.3433-19-1699D77423221516001
5/4/17 19:595/2/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.dm1,38735.4633396599D7241512181712000
5/4/17 19:595/2/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.dm-3,753109.9833-34-2699D7241512181712000
4/5/17 21:274/5/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d47725.4833192594D33-10-22-31-1-3-10119
4/5/17 21:274/5/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-1,28493.5833-14-1394D33-10-22-31-1-3-10119
3/7/17 16:183/6/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d47725.4833192789D333-2210-50-6-4-133
3/7/17 16:183/6/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-1,23590.0133-14-1389D333-2210-50-6-4-133
2/8/17 16:162/6/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d47725.4833192984D3718-191-2-5-710-1221
2/8/17 16:162/6/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-1,22689.3533-14-1484D3718-191-2-5-710-1221
1/17/17 16:391/12/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d47725.4833193179M4826-8-181961-2-1-2-8-1
1/17/17 16:391/12/17EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-1,33797.4733-14-1579M4826-8-181961-2-1-2-8-1
11/4/16 17:0111/2/16EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d51025.4833204564D4914-16-21-25-23-21-624-8023
11/4/16 17:0111/2/16EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-1,35290.1333-15-1964D4914-16-21-25-23-21-624-8023
9/6/16 17:199/2/16EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d51025.4833205159D1356833149110-1-11-30-23
9/6/16 17:199/2/16EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-2,084115.7833-18-2359D1356833149110-1-11-30-23
6/2/16 18:585/31/16EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d51025.4833205457D148522313-7-510-11-213-18
6/2/16 18:585/31/16EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-1,78399.0433-18-2457D148522313-7-510-11-213-18
5/18/16 20:175/16/16EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d00.0033226855D134533216-6-7-5-4-22013-13
5/15/15 18:265/13/15EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d00.00332925D82525-1-7-653002102057
10/27/14 19:3210/24/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d94431.47333027D355144381591710139111126
10/27/14 19:3210/24/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-3,428114.2533-30-5327D355144381591710139111126
10/3/14 19:0310/3/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d78731.473325999%27D-345391865111014213246
10/3/14 19:0310/3/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-2,625105.0033-25-4827D-345391865111014213246
9/11/14 17:369/10/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d78731.473325999%27D-63936228312-114323637
9/11/14 17:369/10/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-2,500100.0033-25-4827D-63936228312-114323637
8/1/14 19:187/30/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d64627.77332366827D-142638107356238313767
8/1/14 19:187/30/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-2,14192.0033-23-4727D-142638107356238313767
7/1/14 16:346/27/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d69427.773325999%26D-15283016-1621107194964
7/1/14 16:346/27/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-2,17587.0033-25-4926D-15283016-1621107194964
4/16/14 17:534/14/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d69427.773325999%27D11-58141110981-1772776
4/16/14 17:534/14/14EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-2,05082.0033-25-4827D11-58141110981-1772776
10/9/12 06:0410/4/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d32027.7733128325D5849526732-2-22-19-19-14-21-31
10/9/12 06:0410/4/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-1,270110.1433-12-3125D5849526732-2-22-19-19-14-21-31
7/27/12 17:457/25/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d1,07424.42334425D7743312561-12-2-6-6-18-14-34
7/27/12 17:457/25/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-4,621105.0333-44-6325D7743312561-12-2-6-6-18-14-34
6/14/12 19:036/14/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d50521.96332398025D6663330568316510-7-29
6/14/12 19:036/14/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-2,22696.8033-23-4825D6663330568316510-7-29
5/14/12 16:245/11/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d70722.95333125D66-518151615-2-1-1-38173-15
5/14/12 16:245/11/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-2,61484.8833-31-5525D66-518151615-2-1-1-38173-15
5/8/12 19:555/7/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d31213.013324999%25D75-3111813205-10-21185-22
5/8/12 19:555/7/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-2,04285.0733-24-4925D75-3111813205-10-21185-22
2/28/12 18:252/28/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d37831.4733127927D60-1541701-3-10-31193517
2/28/12 18:252/24/12EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.dm-99073.3733-14-3327D60-1541701-3-10-31193517
5/19/11 17:065/18/11EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS-33989.2633-4-1131D180803919621-2-2-7-23-24-8
5/16/11 19:105/12/11EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d36518.26332014034D1837534-13530-1-1-4-23-23-6
5/16/11 19:105/12/11EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-1,77288.6033-20-3734D1837534-13530-1-1-4-23-23-6
5/10/11 21:585/9/11EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.m-19488.1433-2-634D178753420853-11-3-28-14-4
3/1/11 16:492/25/11EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS-15586.0233-2-536D2068246294-2-404644-13-14
12/1/10 18:0811/30/10EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d15011.4933134940D167612515101002203230-6
12/1/10 18:0811/30/10EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-48466.1933-7-1640D167612515101002203230-6
11/24/10 17:0011/22/10EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d2211.49332634D169612915-221-102232834-5
11/24/10 17:0011/22/10EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-7367.0033-1-334D169612915-221-102232834-5
5/14/10 20:025/13/10EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d38030.43331330217D836326182-1-111-47143176
5/14/10 20:025/13/10EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-1,265101.2333-13-4317D836326182-1-111-47143176
5/11/10 20:555/10/10EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.m-119100.6333-1-717D805927161-4-4-2225173176
11/20/09 18:4311/18/09EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d00.003331519D6169292714510026112365
11/20/09 18:4311/18/09EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-20381.0333-3-1219D6169292714510026112365
6/1/09 16:515/28/09EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearM.d24330.433387718D2711301571001-13-32756
6/1/09 16:515/28/09EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.d-51264.0033-8-3018D2711301571001-13-32756
5/13/09 16:045/11/09EWEdwards Lifesciences CorpDEHealthOrthopOrthopedic, Prosthetic & SurgBobo Donald E JrCAOCVP,HearS.m-6063.0133-1-519D2812183410-2-102552962



DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing



S - SaleSale of securities on an exchange or to another person

S - Sale+OESale of securities on an exchange or to another person (after option exercise)

F - TaxPayment of exercise price or tax liability using portion of securities received from the company

P - PurchasePurchase of securities on an exchange or from another person


Return to top
Contact
Copyright © 2017 OpenInsider.com. All rights reserved.




